Salta al contenuto
info@fondazioneanthem.it
Fondazione Anthem
AdvaNced Technology for Human centEred Medicine
it
en
ANTHEM
L’iniziativa
Partner
Trasparenza
Le Sedi
Governance
Consiglio di Amministrazione
Assemblea Generale
Coordinamento
Advisory Board Industriale
Advisory Board Pazienti
Advisory Board Istituzionale
Gli Spoke
Spoke 1
Spoke 2
Spoke 3
Spoke 4
Education
News
Eventi
Bandi e gare
Paper
Newsletter
Contatti
ANTHEM
L’iniziativa
Partner
Trasparenza
Le Sedi
Governance
Consiglio di Amministrazione
Assemblea Generale
Coordinamento
Advisory Board Industriale
Advisory Board Pazienti
Advisory Board Istituzionale
Gli Spoke
Spoke 1
Spoke 2
Spoke 3
Spoke 4
Education
News
Eventi
Bandi e gare
Paper
Newsletter
Contatti
it
en
Spoke 4
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
14 Giugno 2023
×
Condividi Articolo
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.